DD in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with DD today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
DuPont supplies materials that customers use to build products, package medical supplies and treat water. Nearly all its revenue comes from product sales to manufacturers and distributors. Following the separation of its electronics business, it has two businesses of broadly similar revenue size: Diversified Industrials and Healthcare & Water Technologies, with industrials the larger of the two.
In industrials, DuPont sells building materials such as TYVEK house wrap and STYROFOAM insulation for construction and renovation. It also makes engineered parts, lubricants and adhesives used by manufacturers in markets such as automotive and aerospace. In healthcare, it supplies TYVEK medical packaging and medical-device components, alongside design, prototyping and manufacturing services. Its water business sells products such as FILMTEC filtration elements that industrial and municipal customers use to purify water and treat wastewater.
Sales depend on demand and customer ordering in these construction, manufacturing, healthcare and water markets. Selling products also requires meeting safety and regulatory standards: in most jurisdictions, DuPont must test products and obtain approvals, and failure to secure required permits or approvals can prevent it from producing or selling them.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Beyond this list, watch 3M for competition in industrial protective products; DuPont’s water-filtration business also depends on industrial and municipal treatment investment.
Owens Corning competes with DuPont’s STYROFOAM insulation, and construction and remodeling demand moves both companies’ building-product sales. Watch Owens Corning’s insulation sales for a read on the market behind DuPont’s building business, where weak construction reduced volumes in 2025.
H.B. Fuller competes with DuPont to supply manufacturers with adhesives that hold products together in demanding assembly applications. Its industrial-adhesive sales and customer-specific technical work are worth watching alongside DuPont’s BETAFORCE and BETASEAL structural adhesives.
Huntsman competes for building and industrial customers served by DuPont: its polyurethane insulation systems rival DuPont’s insulation, while its advanced-materials adhesives rival DuPont’s structural bonding products.
Illinois Tool Works competes with DuPont through industrial adhesives and fluids used to bond and lubricate parts. Both also sell to automotive and construction customers, giving DuPont holders another view of demand in those markets.
Celanese’s high-performance polymers serve automotive, medical and industrial manufacturers that overlap with buyers of DuPont’s remaining engineered components and healthcare materials. Watch its Engineered Materials business for demand from those customers, rather than treating it as a comparison with DuPont’s divested businesses.
Eastman Chemical shares several demand markets with DuPont: it sells advanced plastics and functional materials to automotive, building, medical and packaging customers, while DuPont supplies specialty materials to those same markets.
Chemours shares eligible legacy PFAS costs with DuPont under an agreement, so litigation outcomes and its ability to pay matter to DuPont’s exposure. Watch settlement costs, cleanup obligations and Chemours’ performance of its payment obligations—not just sales of its refrigerants and specialty materials.
Avient and DuPont both face manufacturers’ production and inventory cycles: Avient buys resins and additives and turns them into tailored polymers and composites, while DuPont sells engineered components and medical-device materials. Watch Avient’s Specialty Engineered Materials demand for another view of manufacturers’ purchasing cycles.
Amcor competes with DuPont for medical-device and pharmaceutical packaging customers, selling healthcare packaging against DuPont’s medical-packaging offerings, including TYVEK.
Dow and DuPont serve overlapping manufacturing markets: Dow sells polymers for packaging and infrastructure, while DuPont supplies packaging materials, building products and automotive components. Watch Dow’s Packaging & Specialty Plastics demand from packaging, mobility and infrastructure customers as a separate view of those shared markets.
PPG’s coating sales follow the construction and manufacturing cycles that also drive DuPont’s building materials and industrial components; PPG sells to building contractors, consumers and manufacturers in transportation and packaging. Compare its architectural and industrial coating demand to distinguish building weakness from manufacturing demand in DuPont’s results.
Housing Starts (Sep)
New-home construction readings track homebuilding activity and sales; more building can increase purchases of DuPont’s TYVEK® house wrap, STYROFOAM™ insulation and CORIAN® solid surface, supporting product sales.
Expected1.31MLast release1.275M
If it comes in above expectations
If the reading is above the 1.31M estimate, it is above the previous 1.275M. More starts, permits or new-home sales may support more building and demand for DuPont’s house wrap, insulation and solid surface products, increasing customer purchases; less activity may reduce them.
If it comes in below expectations
Fewer starts, permits or new-home sales may mean less building and lower customer purchases of DuPont’s house wrap, insulation and solid surface products; stronger activity may lift those purchases.
Illinois Tool Works Inc. earningsITW
Illinois Tool Works’ report will show how automotive and construction customers are buying industrial bonding and lubrication products that compete with DuPont’s offerings.
Look for demand in Illinois Tool Works’ industrial bonding products. Strong demand would show customers are still buying, though it could also mean a competitor is winning more orders; weakness would point to softer demand in these applications or a tougher competitive setting for DuPont. This report alone cannot separate the two.
PPG Industries, Inc. earningsPPG
PPG’s report will separate architectural from industrial coating demand, helping show whether the customers behind DuPont’s building and industrial products are buying more or less.
Separate PPG’s architectural-coating demand from its industrial-coating demand. Strength in the first and weakness in the second would point to firmer building markets but continued pressure from manufacturing customers; strength in both would suggest a better backdrop for both groups of DuPont customers. Coating demand is a signal from shared customers and market cycles, not a measure of DuPont’s own sales.
Durable Goods Orders MoM (Sep)
Durable-goods orders track buying of long-lasting goods and equipment; stronger orders can lift demand for DuPont’s engineered components and systems sold to automotive, aerospace and other industrial customers, bringing more product sales.
Expected0.2%Last release-0.1%
If it comes in above expectations
If the reading is above the 0.2% estimate, it is above the previous -0.1%. More orders may prompt DuPont’s automotive, aerospace and other industrial customers to buy more engineered components and systems, lifting sales volumes; fewer orders may reduce those purchases and volumes.
If it comes in below expectations
Orders below expectations may lead DuPont’s automotive, aerospace and other industrial customers to buy fewer engineered components and systems, reducing sales volumes; stronger orders may lift them.
DuPont de Nemours, Inc. earningsThis company
DuPont’s report will show whether Healthcare & Water Technologies is still turning growth into profit and whether Diversified Industrials is beginning to recover.
Read each segment’s sales, volume and local price and product mix alongside Operating EBITDA, DuPont’s segment profit measure with specified adjustments. In 2025, Healthcare & Water Technologies sales rose 9% on 7% volume growth and Operating EBITDA rose 15%; Diversified Industrials sales fell 3% and Operating EBITDA fell 5%. Continued volume and profit growth in the first segment, alongside improvement in the second, would show growth broadening. A slowdown in the first and continued weakness in the second would show growth remains concentrated.
Amcor plc earningsAMCR
Amcor’s report will show demand from healthcare-packaging customers and how this competitor is performing in a business that overlaps with DuPont’s.
Watch sales in Amcor’s healthcare-packaging business. Stronger sales would show customer purchasing is holding up, but could also mean a competitor is winning more orders; weaker sales could reflect softer demand or Amcor-specific issues. The report offers a market and competition signal, but cannot by itself establish that DuPont’s TYVEK packaging sales moved the same way.
Owens Corning earningsOC
Owens Corning’s insulation sales will show how construction and remodeling customers are buying in a market where it competes with DuPont’s STYROFOAM insulation.
Look at Owens Corning’s insulation sales. Stronger sales would show that construction or remodeling customers are still buying insulation, but could also reflect a competitor winning more orders; weaker sales could signal soft demand for building products, a headwind for DuPont’s STYROFOAM business. The result alone cannot separate market demand from changes in competitive share.
The Chemours Company earningsCC
Chemours’ report will show how it is handling eligible shared legacy PFAS costs and payment obligations, which matters to DuPont’s potential exposure.
Watch Chemours’ disclosures on eligible legacy PFAS costs, payment obligations and whether it is meeting them. Clear cost arrangements and payments as agreed would reduce uncertainty around DuPont’s shared exposure; rising costs or limited ability to pay could increase DuPont’s potential cash burden. The effect depends on the cost-sharing terms and actual payments, not Chemours’ overall results alone.
Industrial Production MoM (Oct)
Industrial production and capacity use track factory, mining and utility output and how much capacity is being used; stronger activity can increase automotive, aerospace and other industrial customers’ purchases of DuPont’s engineered components, systems and process solutions, supporting sales.
Stronger factory, mining and utility output may signal that DuPont’s automotive, aerospace and other industrial customers will buy more of its engineered components, systems and process solutions; weaker output may point to fewer purchases.